NeOnc Technologies Holdings, Inc. Common Stock

NTHINASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
5.34 USD
↘ 0.02 (0.37%)AT CLOSE (11:59 AM EDT)
5.39
↗ 0.05 (0.84%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
5.39
↗ 0.05 (0.84%)
🔴Market: CLOSED
Open?$5.32
High?$5.66
Low?$5.29
Prev. Close?$5.36
Volume?82.0K
Avg. Volume?92.4K
VWAP?$5.43
Rel. Volume?0.89x
Bid / Ask
Bid?$4.54 × 100
Ask?$6.61 × 100
Spread?$2.07
Midpoint?$5.58
Valuation & Ratios
Market Cap?138.9M
Shares Out?26.0M
Float?7.2M
Float %?31.7%
P/E Ratio?N/A
P/B Ratio?-10.50
EPS?-$1.49
Dividend?0.00%
Ex-Dividend?N/A

NTHI is currently priced at $5.34. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (292.0%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.

Technical & fundamental data as of May 22, 2026.

News
Profile
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.
Themes
Healthcare - Oncology›Targeted Therapy & Precision OncologyBiotech - Drug Development›Neuroscience & CNS
Employees
5
Market Cap
138.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.neonc.com
Listed
2025-03-26
Address
23975 PARK SORRENTO
CALABASAS, CA 91302
Phone: 310 663 7831
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
79
Piotroski F-Score?0/9Weak
Altman Z-Score?-84.28Distress
Confidence?37%Very Low
Full Fundamental Analysis →
Short InterestModerate
Short % of Float?3.82%Low
Short Interest?274.8K
Days to Cover?3.9
Free Float7.2M
Avg Daily Volume71.4K
Settlement Date2026-04-30
Financial Health
Current Ratio?0.13Weak
Quick Ratio?0.13Weak
Cash Ratio?0.01Low
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
-10.50CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.2CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
292.0%STRONG▾
ROA?
S&P
3
-1,160.3%WEAK▾
Cash Flow & Enterprise
FCF?$-22205666
Enterprise Value?$138.8M
Fundamentals ratios updated end of day
MarketsMoversWatchlist